Atogepant Prevents Migraine in Adults

WEDNESDAY, June 15, 2022 -- Atogepant appears to be effective and well tolerated for the preventive treatment of migraine, according to a study published online June 8 in JAMA Network Open. Richard B. Lipton, M.D., from Albert Einstein College of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news